Sunnov Investment Backs Tate & Lyle London Exit

The all-cash agreement valuing the British sweetener and ingredients group at roughly $3.6 billion ends an 87-year London listing and forges a near-$10 billion speciality-ingredients leader spanning sweetening, texture and clean-label innovation.

A defining transaction is reshaping the global ingredients industry this week, and Sunnov Investment counts among the managers studying it closely. Ingredion Incorporated has agreed to acquire Tate & Lyle PLC in an all-cash deal that values the British group at approximately $3.6 billion and would create a business generating close to $10 billion in annual revenue. The agreement follows months of negotiation and several earlier approaches from the Chicago-based manufacturer, and it broadens Ingredion's speciality-ingredients platform while adding complementary capabilities in multi-ingredient systems and recipe development across alternative sweeteners, texture modification, sugar reduction, mouthfeel, fortification and clean-label formulation.

The structure values Tate & Lyle's equity at around $3.6 billion, with total enterprise value reaching roughly $5 billion once the British company's debt is included, and it proceeds through a court-sanctioned scheme of arrangement under the United Kingdom Companies Act 2006. Completion requires shareholder approval, court sanction and antitrust clearances across several jurisdictions, and it would conclude an 87-year listing on the London Stock Exchange, marking another household name's departure from the UK market.

Shareholders stand to receive cash consideration equivalent to about $8 per share, a 59% premium to the closing price on the final trading day before the approach became public, together with entitlement to dividends of up to roughly $0.3 per share. Tate & Lyle stock has climbed as much as 15% to around $7.6 in London since the announcement, though it sits below the offer, a signal that some investors weigh execution risk. Observers point to regulatory scrutiny as the central question, given a combined business that would hold an estimated 15% share of the current global market for alternative sweeteners.

The deal is "a deliberate bet on scale in a category," in the assessment of Thomas Gardner, private equity director at Sunnov Investment, who reads its logic as structural rather than opportunistic; it is one, he adds, "where reformulation has shifted from a marketing preference to a regulatory and demographic certainty, and where breadth across texture, sweetening and fortification is becoming the price of entry." Ingredion has framed the combination as the creation of a global leader in ingredient solutions, pairing its established platform in texturants and speciality starches with Tate & Lyle's expertise in mouthfeel, sweetening and fortification, and uniting supply networks spanning the Americas, Europe, the Middle East and Africa, and Asia Pacific. Completion is anticipated in the second half of 2027, subject to customary conditions, with the extended timeline reflecting the antitrust review such scale invites; the firm has satisfied the United Kingdom takeover requirement for a definitive offer.

Management expects the merged group to generate approximately $10 billion in combined annual revenue and adjusted EBITDA of about $1.8 billion before synergies, with Tate & Lyle contributing revenue of $2.7 billion and adjusted EBITDA of roughly $570 million across its most recent full financial year, alongside close to 5,000 employees and nearly 1,000 patents. Ingredion anticipates approximately $130 million in annual run-rate net cost synergies once integration completes by the end of 2030, around 60% drawn from selling, general and administrative expenses and the remaining 40% from cost of goods sold, with one-time costs of roughly $175 million to capture them. The combination is expected to deliver more than 15% adjusted earnings-per-share accretion for Ingredion shareholders in the first full calendar year following completion, with revenue synergies deliberately excluded from the stated target.

The strategic case rests on demand that continues to compound across the sector's core categories. The global market for alternative sweeteners stands at roughly $4.1 billion at present and is forecast to reach $6.2 billion by 2034, a compound annual growth rate of 4.6% over that horizon, propelled by obesity projected to exceed 1.1 billion adults worldwide by 2030 and by sugar-taxation regimes in the United Kingdom, Mexico and the Philippines that quicken reformulation. Clean-label ingredients follow a similar trajectory, valued at about $31.8 billion currently, up from $28.2 billion a year earlier, and projected to reach $89.7 billion by 2034 at a compound annual rate of 12.2% over the same span. Gardner reads the consolidation through that lens, and in his view "the suppliers positioning now for systems-based solutions, rather than single ingredients, are the ones likely to capture the premium as manufacturers pursue nutrition without surrendering taste or cost."

The deal arrives as consolidation gathers pace across the sector. International Flavors & Fragrances has agreed to divest its food-ingredients business to CVC Capital Partners for approximately $4.3 billion, a unit generating close to $3.1 billion in sales and about $430 million in EBITDA across its latest full year, while retaining a 10% holding, with completion anticipated in the second half of 2027. Set against that transaction, the Ingredion agreement points to an industry reorganising around scale, scientific depth and clean-label capability, and Sunnov Investment continues to track the implications for valuations across texture, sweetening and fortification as suppliers compete for an increasingly exacting customer base.

About Sunnov Investment

Founded in 2012 and headquartered in Singapore, Sunnov Investment manages capital for accredited investors, foundations and endowments across global markets. The firm centres its work on long-only equity strategies, complemented by long/short equity, global macro, event-driven and systematic mandates, and it continues to develop structured routes through which eligible retail participants may take part.

Website: https://sunnov.com

Media enquiries may be directed to Deng Hui at d.hui@sunnov.com

The business is registered as Sunnov Investment Pte. Ltd., UEN 201225494E.

Islamabad

Pess Release Distribution by https://webxfixer.com

This release was published on openPR.